Assessing the magnitude of immunogenic cell death following chemotherapy and irradiation reveals a new strategy to treat pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) continues to have a dismal prognosis in part due to ineffective treatment strategies. The efficacy of some chemotherapies and especially radiotherapy are mediated partially by the immune system. Therefore, we hypothesized that profiling the immune response fol...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Immunol Res
Huvudupphovsmän: Ye, Jian, Mills, Bradley N., Zhao, Tony, Han, Booyeon J., Murphy, Joseph D., Patel, Ankit P., Johnston, Carl J., Lord, Edith M., Belt, Brian A., Linehan, David C., Gerber, Scott A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6946873/
https://ncbi.nlm.nih.gov/pubmed/31719057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-19-0373
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk